Meng, Qing-Qi <br/><br/>
Rosiglitazone enhances the proliferation of neural progenitor cells and inhibits inflammation response after spinal cord injury.  [electronic resource] 

 -  Neuroscience letters  Oct 2011 
 - 191-5 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1872-7972 
<br/><br/><label>Standard No.: </label>10.1016/j.neulet.2011.08.033  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Anti-Inflammatory Agents<br/>Antigens, Nuclear--metabolism<br/>Antimetabolites<br/>Blood-Brain Barrier--drug effects<br/>Bromodeoxyuridine<br/>Cell Differentiation--drug effects<br/>Cell Proliferation--drug effects<br/>Female<br/>Flow Cytometry<br/>Inflammation--drug therapy<br/>Intermediate Filament Proteins--metabolism<br/>Movement--physiology<br/>NF-kappa B--biosynthesis<br/>Nerve Tissue Proteins--metabolism<br/>Nestin<br/>Neural Stem Cells--drug effects<br/>PPAR gamma--agonists<br/>Rats<br/>Rats, Sprague-Dawley<br/>Recovery of Function--physiology<br/>Rosiglitazone<br/>Spinal Cord Injuries--drug therapy<br/>Thiazolidinediones--pharmacology